PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Discovery Simulator, a new software designed for ...
PRINCETON, N.J.--(BUSINESS WIRE)--Certara, Inc., the global leader in biosimulation, today announced the release of version 20 of its Simcyp™ Physiologically-based Pharmacokinetic (PBPK) Simulator ...
Certara, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has announced the released of version 16 of its ...
Certara, a leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, announced that the Office of Generic Drugs (OGD), US ...
Unique capabilities expand the types of drugs, modalities, populations, and development questions modeled using the Simcyp PBPK Simulator Certara’s industry-leading Simcyp PBPK Simulator improves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results